Please wait...
About This Project
We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Browse Other Projects on Experiment
Related Projects
Community-based Leishmaniasis research in Sri Lanka
Leishmaniasisis a neglected tropical parasitic diseases in the world and is spread by the bite of sand flies...
Antibiotic Resistance: Between the Environment and Our Bodies
Bacteria have evolved many genes to make them resistant to most of our antibiotics. Such genes can be moved...
Making Inexpensive Insulin Using Microalgae
This page serves as an archive of our first proof-of-concept experiments to genetically modify microalgae...